PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
28-Mar-2023 iOnctura awarded UK’s MHRA Innovation Passport for entry into innovative licensing and access pathway (ILAP) iOnctura
28-Mar-2023 Transgene Announces Upcoming Investor Meetings Transgene
27-Mar-2023 HpVac reports positive effects of its lead compound HpVac-R13 in a murine model of allergic asthma following oral administration HpVac
23-Mar-2023 Evaxion presents a new source of AI-derived immunotherapeutic targets strongly associated with the overall survival of cancer patients Evaxion Biotech
23-Mar-2023 MIG Capital leads €13 million Series A financing of microbiome therapeutics biotech mbiomics MIG Capital
23-Mar-2023 Aqilion to recieve 20.1 MSEK after conversion of outstanding warrants Aqilion
22-Mar-2023 AbCellera and RQ Bio Partner to Accelerate the Advancement of New Therapies for Infectious Disease RQ Biotechnology
22-Mar-2023 CD Formulation Supplies Active Ingredients, Antioxidants, and Chelating Chemicals for Cosmetic Industry CD Formulation
22-Mar-2023 Alfa Chemistry Announces to Participate in the Upcoming Pittcon Conference & Exposition 2023 Alfa Chemistry
21-Mar-2023 Tiziana Life Sciences Announces Purchase of Common Shares by Chairman and Acting CEO Tiziana Life Sciences
21-Mar-2023 SpyBiotech Receives Grant to Advance Novel SpyVector Platform That Improves Efficacy and Boosting Capability of Adenovirus-based Vaccines Against Current and Future Pandemic Viruses SpyBiotech
17-Mar-2023 Eluceda Develops ‘Two-Minute’ Covid Vaccine Authentication Test Eluceda
16-Mar-2023 Clinion Launches Revolutionary AI-Powered Medical Coding Solution for Clinical Trials clinion
14-Mar-2023 PBD BIOTECH’S NOVEL LYOPHILIZED PCR REACTION BEAD REDUCES COST OF TRANSPORT AND EXTENDS SHELF-LIFE FOR ACTIVE TB TEST PBD BIOTECH
14-Mar-2023 Synaffix Announces Expansion of ADC Collaboration with MacroGenics Synaffix
14-Mar-2023 Teitur Trophics Raises EUR 28M in Series A Financing to Advance the Development and Treatment for Neurodegenerative Diseases Teitur Trophics
14-Mar-2023 Pioneering biotech firm secures second FDA designation of year to develop world’s first treatment for rare, incurable and deadly disease SynaptixBio
14-Mar-2023 ExeVir Bio and VIB Announce Data on a New Therapy for Prevention and Treatment for COVID-19 ExeVir Bio
13-Mar-2023 Recipharm's Arranta Bio expands RNA process development capacity by 50 percent to meet increased customer demand Recipharm
13-Mar-2023 Alfa Chemistry to Present at the Upcoming ACS Spring 2023 Conference Alfa Chemistry